Balanced news tone
News Sentiment
SPARC sentiment intelligence
Sun Pharma Advanced Research Company Limited news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Weighted score
49
Balanced news tone
14 relevant articles
Price is moving more forcefully than the current news tone suggests.
95/100 classification confidence.
directly relevant articles
high-authority source matches
+6.4% over one week, +13.5% over four weeks, trend active, and near fair-value range.
Concerns Surrounding Sun Pharma Advanced Research's (NSE:SPARC) Performance
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Primary event
Market update
95/100 classification
One-week reaction
6.4%
Price confirming higher
Trend fit
Trend active
13.5% over four weeks
Fair value
16.1%
Near fair-value range
Sentiment Mix
Positive, neutral, negative
Positive
2
Neutral
10
Negative
2
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
Above 50
Neutral zone
Below 50
News Tape
Relevant headlines
simplywall.st
Direct company coverage
Concerns Surrounding Sun Pharma Advanced Research's (NSE:SPARC) Performance
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- simplywall.st
Moneycontrol.com
Direct company coverage
Trade Spotlight: How should you trade SPARC, Gland Pharma, Techno Electric, GE Power India, Supriya...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 25 May 2026 07:00
- Source
- Moneycontrol.com
Moneycontrol.com
Direct company coverage
Stocks to Watch Today: Emcure, Aurobindo Pharma, HFCL, RBL Bank, Coal India, Tata Steel, ITC Hotels, Power...
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 May 2026 07:00
- Source
- Moneycontrol.com
scanx.trade
Direct company coverage
Sun Pharma Advanced Research sells Priority Review Voucher for US $195 million
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 01 May 2026 07:00
- Source
- scanx.trade
scanx.trade
Direct company coverage
Sun Pharma Advanced Research Promoter Declares No Share Encumbrance for Q4FY26
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 22 Apr 2026 07:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Investors in Sun Pharma Advanced Research (NSE:SPARC) from three years ago are still down 26%, even after 13% gain this past week
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 04 Feb 2026 08:00
- Source
- simplywall.st
scanx.trade
Direct company coverage
Sun Pharma Advanced Research Company Issues Corrigendum to EGM Notice Following NSE Observations
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 29 Jan 2026 08:00
- Source
- scanx.trade
simplywall.st
Direct company coverage
Sun Pharma Advanced Research Company Limited (NSE:SPARC) surges 21%; private companies who own 46% shares profited along with insiders
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 03 Dec 2025 08:00
- Source
- simplywall.st
The Economic Times
Direct company coverage
Sun Pharma Advanced Research jumps 11%, extends 2-day rally as US court clears Sezaby PRV
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Dec 2025 08:00
- Source
- The Economic Times
Equitymaster
Direct company coverage
Why Sun Pharma Advanced Share Price is Rising
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 03 Dec 2025 08:00
- Source
- Equitymaster
The New Indian Express
Direct company coverage
HCL Tech, HDFC Bank, Sun Pharma, Tata Motors stocks rise on US Fed rate cut
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 18 Sep 2025 07:00
- Source
- The New Indian Express
The Economic Times
Direct company coverage
Sun Pharma Advanced Research shares tank 20% after psoriasis drug fails Phase 2 trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2025 07:00
- Source
- The Economic Times
Fortune India
Direct company coverage
Sun Pharma Advanced Research stock plunges 20% after key psoriasis drug fails Phase 2 trials
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Jun 2025 07:00
- Source
- Fortune India
Business Standard
Direct company coverage
Sun Pharma Advanced Research hits 20% lower band; what's rattling Street?
- Tone
- Negative 34/100
- Event
- Market update
- Published
- 04 Jun 2025 07:00
- Source
- Business Standard